No Hypertensive Disorder of Pregnancy; No Preeclampsia-eclampsia; No Gestational Hypertension; No Hellp Syndrome. Vascular Disorder of Pregnancy Speaks for All
暂无分享,去创建一个
[1] F. Figueras,et al. Characterization of Atypical Preeclampsia , 2015, Fetal Diagnosis and Therapy.
[2] S. Davidge,et al. Molecular mechanisms of maternal vascular dysfunction in preeclampsia. , 2015, Trends in molecular medicine.
[3] B. Nagy,et al. Genetic Aspects of Preeclampsia and the HELLP Syndrome , 2014, Journal of pregnancy.
[4] D. Henderson-smart,et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. , 2014, The Cochrane database of systematic reviews.
[5] M. Gabryś,et al. Inability to have children caused by recurrent HELLP syndrome in early pregnancies - implications for a review of literature. , 2013, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[6] E. Stekkinger,et al. Metabolic syndrome and the risk for recurrent pre‐eclampsia: a retrospective cohort study , 2013, BJOG : an international journal of obstetrics and gynaecology.
[7] K. Heimdal,et al. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[8] S. Tyagi,et al. Late postpartum eclampsia , 2012, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
[9] N. Vitoratos,et al. Molecular Mechanisms of Preeclampsia , 2012, Journal of pregnancy.
[10] D. Schust,et al. Preeclampsia: multiple approaches for a multifactorial disease , 2012, Disease Models & Mechanisms.
[11] R. Bahado-Singh,et al. Delayed Postpartum Preeclampsia and Eclampsia: Demographics, Clinical Course, and Complications , 2011, Obstetrics and gynecology.
[12] Mandy J. Bell. A historical overview of preeclampsia-eclampsia. , 2010, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.
[13] B. LaMarca,et al. The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. , 2010, Minerva ginecologica.
[14] J. Tukur. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. , 2009, Annals of African medicine.
[15] Eric Jauniaux,et al. Antihypertensive Therapy and Central Hemodynamics in Women With Hypertensive Disorders in Pregnancy , 2009, Obstetrics and gynecology.
[16] P. Gracia,et al. Maternal deaths due to eclampsia and HELLP syndrome , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[17] A. Fukamizu,et al. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension , 2008, Vascular health and risk management.
[18] A. Tranquilli,et al. HELLP syndrome and placental inflammatory pathology. , 2008, Minerva ginecologica.
[19] B. Sibai,et al. HELLP syndrome: an atypical presentation. , 2008, American Journal of Obstetrics and Gynecology.
[20] G. Krikun,et al. The Placental Syncytium and the Pathophysiology of Preeclampsia and Intrauterine Growth Restriction , 2008, Annals of the New York Academy of Sciences.
[21] A. Seicean,et al. HELLP syndrome - a multisystemic disorder. , 2007, Journal of gastrointestinal and liver diseases : JGLD.
[22] A. Hingorani,et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.
[23] R. Harskamp,et al. Preeclampsia: At Risk for Remote Cardiovascular Disease , 2007, The American journal of the medical sciences.
[24] M. Permezel,et al. Gestational Diabetes Mellitus: Clinical Predictors and Long-Term Risk of Developing Type 2 Diabetes , 2007, Diabetes Care.
[25] M. Olovsson,et al. The risk of maternal ischaemic heart disease after gestational hypertensive disease. , 2006, BJOG : an international journal of obstetrics and gynaecology.
[26] R. D'Agostino,et al. Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.
[27] I. Duncan. Pre-eclampsia, eclampsia and the thrombotic microangiopathic syndromes of pregnanacy , 2005 .
[28] A. Smit,et al. Abnormal Endothelium-Dependent Microvascular Reactivity in Recently Preeclamptic Women , 2005, Obstetrics and gynecology.
[29] B. Sibai. Diagnosis, prevention, and management of eclampsia. , 2005, Obstetrics and gynecology.
[30] MarkA. Brown. Pre‐eclampsia: a lifelong disorder , 2003, The Medical journal of Australia.
[31] B. Cha,et al. Metabolic Syndrome and Cardiovascular Disease , 2003 .
[32] R. Crupi,et al. A current concept of eclampsia. , 2003, The American journal of emergency medicine.
[33] J. Kuller,et al. Preeclampsia into eclampsia: toward a new paradigm. , 2000, American journal of obstetrics and gynecology.
[34] B. Sibai,et al. Eclampsia. VIII. Risk factors for maternal morbidity. , 2000, American journal of obstetrics and gynecology.
[35] K. Lim,et al. Circulating Factors as Markers and Mediators of Endothelial Cell Dysfunction in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[36] M. Jacobs,et al. HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) pathophysiology and anesthetic considerations. , 1997, AANA journal.
[37] C. Redman,et al. Eclampsia in the United Kingdom , 1994, BMJ.
[38] F. Rengo,et al. Hemodynamic effects of magnesium sulfate on the normal human heart. , 1991, The American journal of cardiology.
[39] B. Sibai. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? , 1990, American journal of obstetrics and gynecology.
[40] T. N. Abdella,et al. Eclampsia: V. The incidence of nonpreventable eclampsia , 1986 .
[41] O. Ratnoff,et al. Intravascular hemolysis, thrombocytopenia and other hematologic abnormalities associated with severe toxemia of pregnancy. , 1954, The New England journal of medicine.
[42] D. Hawks. The American College of Obstetricians and Gynecologists (ACOG) , 2014 .
[43] B. Sibai. HIGH-RISK PREGNANCY SERIES: AN EXPERT’S VIEW Diagnosis, Controversies, and Management of the Syndrome of Hemolysis, Elevated Liver Enzymes, and Low Platelet Count , 2004 .
[44] B. Sibai,et al. Biochemical corroboration of endothelial involvement in severe preeclampsia. , 1995, American journal of obstetrics and gynecology.